Summit Biolabs, Inc. — Form D
Summit Biolabs, Inc. of AURORA, CO, a company, filed a Form D exempt-offering notice with the SEC on 2020-08-20. The offering totals $12.0M, of which $235K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-08-20
- Form: D
- Accession: 0001814370-20-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $12.0M
- Amount sold: $235K
- Remaining: $11.8M
- Investors: 5
- Date of first sale: 2020-08-19
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-373631
Issuer
- Name: Summit Biolabs, Inc.
- CIK: 0001814370
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 12635 E. MONTVIEW BLVD., AURORA, CO, 80045
- Phone: 3037868310
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Robert E Blomqust | Director | AURORA, CO |
| Shi-Long E Lu | Director | AURORA, CO |
| Robert E Blomqust | Executive Officer | AURORA, CO |
| Shi-Long E Lu | Executive Officer | AURORA, CO |
More